Ophthalmology and the Internet.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to R L Lindstrom.
Explore the source record for details and available documents.
A 59-year-old man underwent pterygium excision with intraoperative application of 0.2 mg/ml (0.02%) mitomycin-C placed on the scleral bed for 3 min. A sliding conjunctival flap was used to cover the exposed limbus and sclera. Five weeks after the original surgery, the patient had mild trauma and noted decreased vision. At that time, it was noted that he had a corneoscleral melt with perforation. The patient was managed with a lamellar transplant in this area. Intraoperative single-dose application of topical mitomycin-C can be associated with serious complications. This case occurred despite the fact that this patient received the lowest dose used in a series of 25 eyes using the same technique without any other complications. Although topical mitomycin-C is effective as an adjunct to pterygium surgery and may reduce recurrence, the safety and efficacy of various concentrations and dosing schedules need further definition.
Radial keratotomy (RK) is a common surgical technique for correcting myopia. The RK incisions, like any corneal incisions, permanently weaken the cornea and this structural weakening can cause several complications and side effects, including diurnal fluctuation, progressive hyperopic shift, and the potential for traumatic rupture of the keratotomy scars. I describe a new technique--minimally invasive RK (mini-RK)--that reduces the millimeters of cornea incised and present preliminary laboratory and clinical results. In a cadaver eye study, eight short, deep incisions extending from the 3.0 mm optical zone to the 7.0 mm optical zone produced 92% of the efficacy of full-length incisions to the 11.0 mm optical zone. This finding was confirmed by intraoperative surgical keratometry in six patients in whom a 1% increase in central corneal flattening was achieved when incisions were extended from the mini-RK configurations to full length. In a retrospective evaluation of 100 patients with -1.0 to -6.0 diopters (D) of myopia, 92% of eyes were within 1.0 D of emmetropia and 94% had 20/40 or better uncorrected visual acuity. No significant complications were encountered. Mini-RK may be a useful alternative to reduce the invasiveness of RK but retain its efficacy in eyes with low to moderate myopia.
As part of a clinical trial, photorefractive keratectomy using the VISX 2015 193-nm excimer laser was performed on 91 healthy eyes of 91 patients. Preoperative refractive errors (spherical equivalent) ranged from -1.00 to -7.50 diopters (mean, -4.16 +/- 1.41 diopters). No patient had more than 1 diopter of refractive astigmatism. Six months postoperatively, the average residual refractive error was +0.09 +/- 0.63 diopters (range, -2.13 to +1.63 diopters). Correction within 1 diopter of that attempted was attained in 85 eyes (93%). Uncorrected visual acuity of 20/40 or better was attained in 86 eyes (95%) and was 20/25 or better in 67 eyes (74%). At one year, follow-up information was available on 85 eyes of 85 patients. The average residual refractive error was -0.15 +/- 0.65 diopters (range, -2.50 to +1.63 diopters). Correction within 1 diopter of that attempted was attained in 85 eyes (93%). Uncorrected visual acuity was 20/40 or better in 83 eyes (98%) and was 20/25 or better in 68 eyes (80%). One patient lost three lines of best-corrected visual acuity because of corneal haze, dropping from 20/15 to 20/30, whereas all other patients returned to best-corrected visual acuity within one line of their preoperative best-corrected visual acuity. Photorefractive keratectomy with the 193-nm excimer laser appears to be a useful treatment modality for the reduction of mild to moderate myopia.
As part of a Phase III clinical trial, photorefractive keratectomy using the VISX 2015 193 nm excimer laser was performed on 91 sighted eyes of 91 patients. Preoperative refractive errors (spherical equivalent) ranged from -1.00 diopters (D) to -7.50 D (mean -4.11 D +/- 1.43 D). At six months, average residual refractive error was 0.02 D +/- 0.64 D (range -2.21 D to +1.38 D). Ninety-three percent of eyes were within 1.00 D of attempted correction, 93% had uncorrected visual acuity of 20/40 or better, and 72% achieved uncorrected visual acuity of 20/25 or better. All patients returned to their best corrected visual acuity within one line of their preoperative best corrected visual acuity. Photorefractive keratectomy with the 193 nm excimer laser appears to be useful in reducing low to moderate myopia.
PATIENTS AND METHODS: Photorefractive keratectomy using the VISX 2015 193-nm excimer laser was performed on 134 consecutive eyes of 97 myopic patients by the two authors. Preoperative refractive errors (spherical equivalent) ranged from -1.63 to -14.25 diopters (D) (mean, -5.76 +/- 2.40 D). Follow-up of 6 months was available on 110 eyes. At six months, the average residual refractive error was +0.16 +/- 1.13 D (range -2.88 to +3.38). Correction within 1 D of that attempted was obtained in 77 eyes (70%). Uncorrected visual acuity of 20/40 or better was achieved in 89 eyes (81%), and 20/25 or better in 54 eyes (49%). RESULTS: At one year, follow up was available on 57 eyes. The average residual refractive error was -0.22 +/- 0.87 D (range -3.00 to +2.00 D). Correction within 1 D was achieved in 47 eyes (82%). Visual acuity was 20/40 or better uncorrected in 50 eyes (88%), and 20/25 or better in 35 eyes (61%). One patient lost three lines of best corrected visual acuity and 4 patients lost 2 lines of best corrected visual acuity from corneal haze or irregular astigmatism, while all other patients returned to best corrected visual acuity within one line of their preoperative best corrected visual acuity. CONCLUSION: Photorefractive keratectomy with the 193-nm excimer laser appears to be a useful treatment modality for the reduction of low to moderate myopia.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Intraocular lenses of silicone, hydrogel, or acrylic materials that can be implanted through small incisions are being proposed as an alternative to conventional poly(methyl methacrylate) lenses. The potential of each of these materials to stimulate intraocular inflammation is important in their selection as an implantable material. To investigate the potential of each material, we assessed by clinical slitlamp examination, fluorophotometry, and histopathology the inflammatory response induced in the rabbit eye following phacoemulsification and implantation of hydrogel, silicone, or poly(methyl methacrylate) intraocular lenses. All lenses seemed to be equally well tolerated. In general, the degree of inflammation seen clinically decreased over the four-month study; however, anterior segment fluorophotometry showed continued mild interruption of the blood-aqueous barrier in all lens groups. Fluorophotometry is a sensitive method to assess persistent subclinical anterior segment inflammation.
In a previous paper, we reported finding deficits in the contrast sensitivity functions of patients with diffractive multifocal intraocular lenses (IOL's). The results were consistent with optical measurements of the modulation transfer function (MTF) of the IOL. When this MTF is treated as a linear spatial frequency filter, it predicts the existence of a glare effect; contrast threshold for the recognition of target letters should be elevated by a bright, adjacent stimulus. We tested this prediction by measuring contrast thresholds for recognizing 0.2 degrees Sloan letters on a background luminance of 11.2 cd/m2. The letters were presented inside bright (300 cd/m2) annular rings with inner diameters ranging from 0.42 to 1.22 degrees. Thresholds were measured for seven multifocal subjects, age-matched groups of monofocal subjects and phakic-control subjects, and a young group. Multifocal subjects exhibited a greater glare effect than monofocal subjects, and they in turn exhibited a greater effect than phakic-control subjects. The observed glare effect for multifocal subjects was about twice that expected from the spatial filtering property of the multifocal IOL.
Explore the source record for details and available documents.
Removal of cataract with intraocular lens implantation has been a well-accepted treatment for the past two decades. The development of monofocal intraocular lens technology has represented a significant advance over earlier treatments of cataract and, since the advent of widespread implantation of these lenses, most patients with cataract can achieve good postsurgical vision with the use of bifocal spectacles.
PURPOSE/BACKGROUND: The clinical evaluation of the Food and Drug Administration study of the 3M diffractive multifocal intraocular lens (IOL) is presented here to demonstrate the results of 1-year postoperative data accumulated for 671 patients, the first of whom received the implant in 1987. METHODS: Patients were selected for study if they had absence of preoperative pathology, were at least 60 years of age, and had a reasonable postoperative prognosis. Extensive evaluations took place at 4 to 6 months and 12 to 14 months after surgery, including five different visual acuity measurements and contrast sensitivity. All testing was completed on both eyes. Data from the fellow eye served as a control when implanted with a monofocal IOL. RESULTS: Overall uncorrected distance visual acuity at 1 year after surgery shows 57% patients with 20/40 or better acuity. In this same group, 78% achieved J3 or better near vision, which improved to 82% in the best case group. Uncorrected visual acuity of 20/40 or better and J3 or better was achieved by 50% of best case multifocal IOL patients, compared with 26% of the monofocal best case comparison group. Measurements of contrast sensitivity consistently document a small loss, which is considered clinically insignificant. Statistical analysis of satisfaction ratings shows that predictors of satisfaction include uncorrected distance acuity, final near acuity, and fellow eye spherical equivalent. CONCLUSION: This multifocal lens appears to work very well for most patients, with more than half having functional uncorrected distance and near vision. The study showed several considerations that are important for optimizing clinical performance and patient satisfaction: patient selection, realistic expectations, accurate biometry, and adequate control of surgical procedures.
We compared the safety and efficacy of Optisol (Chiron Ophthalmics, Irvine, California), a new corneal storage medium, with McCarey-Kaufman and Dexsol corneal storage media (Chiron Ophthalmics, Irvine, California) and K-Sol corneal storage medium (Cilco, Huntington, West Virginia). Optisol contains dextran, 2.5% chondroitin sulfate, vitamins, and precursors of adenosine triphosphate (adenosine, inosine, and adenine). In in vitro studies, rabbit and human corneas stored in Optisol were thinner after 12 to 14 days at 4 C than tissue stored in other media. Thymidine uptake showed increased mitotic activity in human corneal endothelial cells cultured in Optisol, compared to Dexsol. Specular microscopic fields showed larger are-as of visibly intact endothelial cells and ultrastructural examination disclosed fewer structural changes in endothelial cells stored in Optisol, compared to tissue stored in Dexsol. In vivo, no clinical signs of epithelial toxicity or histologic evidence of intraocular inflammation were observed in rabbit eyes in which Optisol drops were instilled four times a day for 14 days. Finally, 51 patients undergoing penetrating keratoplasty with tissue stored in Optisol for one to six days (mean, 3.6 days) were enrolled in an uncontrolled, open-label clinical study. The percentage of clear grafts (93%, 41 of 44 patients examined at three months; and 98%, 42 of 43 patients examined at six months) and endothelial cell loss (5.0% and 11.5% at three and six months, respectively) were comparable to data from previous studies that used tissue stored in other short-term and intermediate-term media. The results suggest that Optisol storage preserves corneal endothelial cells for up to two weeks at 4 C, thereby permitting flexibility in the use of donor tissue for corneal transplantation, and that Optisol storage yields thinner tissue, which may allow for more accurate evaluation and more effective surgical manipulation.
Multifocal intraocular lenses are intended to increase depth of focus for patients with cataracts, but optical considerations predict reduced retinal-image contrast. We evaluated visual performance through multifocal intraocular lenses by measuring contrast sensitivity functions and reading speed for age-matched groups with multifocal and monofocal intraocular lenses and two normal control groups. Contrast sensitivity functions of the patients with multifocal lenses did not differ significantly for optical distances differing by 2.5 diopters, indicating substantial depth of focus. Normal and monofocal contrast sensitivity functions were nearly identical, and both were about a factor of two higher than multifocal contrast sensitivity functions. Patients with multifocal lenses showed deficits in reading speed only for low-contrast text (less than 30%) and small letters (0.2 degree and 1.0 degree).